Clinical Roundup Sugemalimab, aumolertinib show clinical benefit in NSCLC, r/r ENKTL June 03, 2022Vol.48 No.22
Clinical Roundup Genetic testing changes cancer treatment plans, Invitae studies suggest June 03, 2022Vol.48 No.22
Clinical Roundup CPI-613 may be used to treat clear cell sarcoma, pancreatic, biliary tract cancer June 03, 2022Vol.48 No.22
Clinical Roundup Lasofoxifene + abemaciclib shows potential in ER+/HER2− breast cancer with ESR1 mutation June 03, 2022Vol.48 No.22
Clinical Roundup SWOG researchers use cell-free DNA methylation to predict chemo benefit in bladder cancer May 27, 2022Vol.48 No.21
Clinical Roundup Roswell Park study: Targeting the E3 ligase activity of MDM2 could help control p53 protein May 27, 2022Vol.48 No.21
Clinical Roundup OSUCCC-James study: Selective dopamine D2 receptor agonists may curb cancer growth, with fewer side effects May 27, 2022Vol.48 No.21
Clinical Roundup Yale study supports use of metabolic therapy in breast cancer May 27, 2022Vol.48 No.21
Clinical Roundup IU cancer researchers refine colorectal cancer classification, identify therapeutic targets May 27, 2022Vol.48 No.21
Clinical Roundup Cedars-Sinai Cancer study shows hormone therapy + pelvic lymph node treatment improves survival in prostate cancer May 27, 2022Vol.48 No.21
